(Q52024766)

20 April 2018

title

Impaired cognitive performance in ornithine transcarbamylase-deficient mice on arginine-free diet. (English)

1 reference

20 April 2018

author name string

D'Hooge R

1

1 reference

20 April 2018

Marescau B

2

1 reference

20 April 2018

Qureshi IA

3

1 reference

20 April 2018

De Deyn PP

4

1 reference

20 April 2018

language of work or name

English

0 references

publication date

1 September 2000

1 reference

20 April 2018

published in

Brain Research

1 reference

20 April 2018

volume

876

1 reference

20 April 2018

issue

1-2

1 reference

20 April 2018

page(s)

1-9

1 reference

20 April 2018

Behavioral and neurotransmitter changes in the urease-infused rat: a model of congenital hyperammonemia.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902589-0

Evidence for a central cholinergic deficit in congenital ornithine transcarbamylase deficiency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902589-0

Abnormal ornithine carbamoyltransferase in mice having the sparse-fur mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902589-0

Ammonia-induced release of neurotransmitters from rat brain synaptosomes: differences between the effects on amines and amino acids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902589-0

Learning in a 14-unit T-maze is impaired in rats following systemic treatment with N omega-nitro-L-arginine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902589-0

Intracerebroventricular injection of N omega-nitro-L-arginine in rats impairs learning in a 14-unit T-maze.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902589-0

Accumulation of large neutral amino acids in the brain of sparse-fur mice at hyperammonemic state.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902589-0

Neonatal onset ornithine transcarbamylase deficiency: A retrospective analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902589-0

Impaired learning in rats in a 14-unit T-maze by 7-nitroindazole, a neuronal nitric oxide synthase inhibitor, is attenuated by the nitric oxide donor, molsidomine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902589-0

Neurologic outcome in children with inborn errors of urea synthesis. Outcome of urea-cycle enzymopathies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902589-0

Retrospective survey of urea cycle disorders: Part 2. Neurological outcome in forty-nine Japanese patients with urea cycle enzymopathies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902589-0

Ornithine Transcarbamylase Deficiency in Mutant Mice I. Studies on the Characterization of Enzyme Defect and Suitability as Animal Model of Human Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902589-0

Sparse-fur (spf) mouse as a model of hyperammonemia: alterations in the neurotransmitter systems.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902589-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902589-0

The role of nitric oxide in passive avoidance learning.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902589-0

Treatment of urea cycle disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902589-0

The molecular basis of the sparse fur mouse mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902589-0

Nitric oxide synthase inhibitors impair reference memory formation in a radial arm maze task in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902589-0

10.1016/S0006-8993(00)02589-0

7 January 2021

Identifiers

DOI

1 reference

20 April 2018

PubMed ID

10973586

1 reference

20 April 2018